secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVANTA INC (NOVT)
CIK:        0001076930
Form:       8-K/A
Filed at:   2026-10-02T20:30:16+00:00
Accession:  0001193125-26-412444
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Novanta 8-K/A shows Runway Buyer (Riverpoint Medical) FY2025 revenue $136.1M, net income $11.5M
--------------------------------------------------------------------------------

- Novanta closed acquisition of Runway Buyer, LLC, parent of Riverpoint Medical, on July 23, 2026 under an Equity Purchase Agreement signed June 8, 2026; deal value not disclosed.
- Runway Buyer FY2025 revenue $136.12M, income from operations $33.84M, net income $11.46M; interest expense of $21.11M offset most operating profit.
- Dec 31, 2025 balance sheet: total assets $351.69M including goodwill $165.23M and intangibles $93.21M; long-term debt $204.97M; member's equity $116.96M.
- FY2025 operating cash flow $27.08M; capex $3.86M; cash $8.19M; debt payments of $22.68M included $11.0M revolver and $11.68M term debt.
- Revenue by geography: US $110.57M, Rest of Americas $13.51M, Europe $6.12M, Asia $2.11M; Riverpoint makes surgical fiber, sutures and needles in US and Costa Rica plants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1076930/000119312526412444/0001193125-26-412444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1076930/000119312526412444/novt-20260722.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-412444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer